Xencor, Inc. (XNCR)
12.32
-0.70
(-5.34%)
USD |
NASDAQ |
May 07, 16:00
12.32
0.00 (0.00%)
After-Hours: 16:59
Xencor SG&A Expense (TTM) : 63.64M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 503.42M |
| Rigel Pharmaceuticals, Inc. | 88.18M |
| Ultragenyx Pharmaceutical, Inc. | 262.27M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.293B |